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Introduction
Tuboovarian abscesses (TOAs) are only considered to be
a problem during a woman’s childbearing years and the
diagnosis appears to be rare in postmenopausal women.
Before this retrospective study, we encountered several
postmenopausal cases of TOA. Despite a wealth of
information about management in women of reproduc-
tive age, there is little in the medical literature related to
analogous care of postmenopausal women. A MEDLINE
search showed several case series detailing the clinical
features of the latter group [1–6], but the differences in
clinical presentations between the two groups are only
mentioned in two [1,2]. In this retrospective study, we
have attempted to provide more detailed information
related to TOA in postmenopausal women.
Materials and Methods
The medical records for all patients with surgical confir-
mation of TOA between January 1, 1992 and December
31, 2000 at National Taiwan University Hospital were
reviewed. Patients were stratified according to meno-
pausal status, with menopause, which is physiologically
correlated with declining estrogen secretion resulting
from the loss of follicular function, defined as perma-
nent cessation of menses (> 1 year). Cases were analyzed
with respect to age, parity, presenting clinical symptoms,
significant medical conditions, history of intrauterine
device (IUD) use, pre- and postoperative diagnoses,
type of surgical procedure, and associated genital
tract or other pelvic pathologies.
As the age and parity distributions were skewed,
the two cohorts were compared using nonparametric
methods, with the Wilcoxon rank sum test used for the
comparison of pre- and postmenopausal patients with
respect to age and parity. Categorical variables were
compared by the χ2 test with STATA version 7.0 (Stata
Corp., College Station, TX, USA).
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Results
A total of 74 patients with a surgical diagnosis of 
TOA were identified. Mean age was 43 years (range,
26–75), with 65 patients premenopausal and nine
postmenopausal.
There was a history of IUD use in 20 premeno-
pausal patients (31%), but none in the postmeno-
pausal patients. The preoperative diagnosis of TOA was
correct in 35 premenopausal patients (54%), but there
were only two postmenopausal counterparts (22%;
Table 1).
Only one subject (1.5%) in the premenopausal
group had concomitant medical problems (i.e. nonin-
sulin-dependent diabetes mellitus) that could have
contributed indirectly to abscess formation. In con-
trast, however, potentially contributing medical prob-
lems were present in six postmenopausal patients
(60%): five with noninsulin-dependent diabetes melli-
tus and one with chronic hepatitis C (Table 2).
Treatment for the postmenopausal patients com-
prised total abdominal hysterectomy and salpingo-
oophorectomy (n = 5; 55%), salpingo-oophorectomy
(n = 2; 22%), and laparotomic drainage (n = 2; 22%).
One of the two drainage patients subsequently under-
went subtotal hysterectomy and bilateral salpingo-
oophorectomy due to abscess recurrence.
Isolated TOA microorganisms were identified in 29
of the premenopausal group (45%) and seven of the
postmenopausal group (78%); however, between-group
comparison of the isolation rates was not statistically
significant (p = 0.082). The predominant organisms
isolated from the abscess aspirates in premenopausal
patients were Escherichia coli (n = 6), Bacteroides fragilis
(n = 4), Actinomyces (n = 4), other Bacteroides species
(n = 3) and Klebsiella pneumoniae (n = 3). The predomi-
nant organisms isolated in postmenopausal patients
were E. coli (n = 3) and Proteus species (n = 2).
Additional abnormal pathology was identified in
12 premenopausal patients (18%): endometriosis
(n = 7; concomitant with adenomyosis and cervical
intraepithelial neoplasm II [CIN II] in one case each);
isolated adenomyosis (n = 4); and stage IA1 cervical
cancer (n = 1). Additional abnormal pathology was
diagnosed in four postmenopausal patients (44%).
Rectosigmoidal diverticulitis was suspected as the cause
of TOA in one case (case 7) perisurgically. One subject
(case 8) had squamous cell carcinoma (SCC) or CIN III
of the cervix on her Pap smear 9 months after the 
initial surgical intervention; however, the woman was
subsequently lost to follow-up. The other two patients
were found to have associated gynecologic malignancy.
One had a preoperative diagnosis of sigmoid colon
cancer, and experienced an uneventful course after seg-
mental resection of the colon, total hysterectomy and
left salpingo-oophorectomy. The other suffered frequent
abscess recurrences, with a large advanced pelvic ade-
nocarcinoma with bladder invasion discovered 12
months after the initial abscess surgery; endometrial
origin was strongly suspected because of the extremely
inhomogeneous thickening detected in the endomet-
rium. Diagnostic curettage was not performed, however,
due to the patient’s poor medical condition.
Group comparison showed significantly lower
median parity (Table 1) for the premenopausal sub-
jects, while the postmenopausal women were more
likely to have contributing medical disorders and con-
comitant pelvic malignant tumors (Table 3).
Discussion
TOA in postmenopausal women is rare; Blumenfeld 
et al found that only 10 of 587 postmenopausal
patients (1.7%) had TOA [3]. In our series, however, the
incidence of TOA was higher (12%), which is in line with
the findings of Hoffman et al (14%) and Protopapas 
et al (18%) [1,2]. Although abdominal pain (89%)
remained the most frequent complaint in our post-
menopausal TOA patients, fever (22%) was reported
less often than in other studies (60–80%) [7]. Further,
the rate of correct preoperative diagnosis of TOA 
in our postmenopausal patients was relatively low
(54% vs. 22%); however, the result is not statistically
Table 1. Clinical characteristics of patients with tuboovarian abscesses
Characteristic
Premenopausal Postmenopausal
p
(n = 65) (n = 9)
Median age (yr) 42 65 < 0.001
Median parity 2 5 < 0.001
IUD history 20 0 0.10
Contributing medical factors 1 6 < 0.001
Preoperative diagnosis of TOA 35 2 0.15
IUD = intrauterine device; TOA = tuboovarian abscess.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3236
S.M. Hsiao, et al
Ta
bl
e 
2.
C
ha
ra
ct
er
is
tic
s 
of
 p
os
tm
en
op
au
sa
l p
at
ie
nt
s 
w
ith
 tu
bo
ov
ar
ia
n 
ab
sc
es
se
s
C
as
e
A
ge
 
Pr
es
en
tin
g 
sy
m
pt
om
s
C
on
tr
ib
ut
in
g 
Pr
eo
pe
ra
tiv
e 
Po
st
op
er
at
iv
e
In
iti
al
 
M
ic
ro
or
ga
ni
sm
A
ss
oc
ia
te
d 
(y
r)
m
ed
ic
al
 fa
ct
or
s
di
ag
no
si
s
di
ag
no
si
s
su
rg
er
y
pa
th
ol
og
y
1
56
Fe
ve
r
D
ia
be
te
s
A
cu
te
 a
pp
en
di
ci
tis
R
ig
ht
 T
O
A
R
SO
N
ot
 c
ul
tu
re
d
N
on
e
Lo
w
er
 a
bd
om
in
al
 p
ai
n
2
63
Lo
w
er
 a
bd
om
in
al
 p
ai
n
D
ia
be
te
s
Si
gm
oi
d 
co
lo
n 
ca
nc
er
 
Le
ft
 T
O
A
 
TA
H
, 
Pr
ot
eu
s v
ul
ga
ris
,
Si
gm
oi
d 
co
lo
n
an
d 
pe
lv
ic
 m
as
s
LS
O
β-
St
re
pt
oc
oc
cu
s
ca
rc
in
om
a
3
69
Fe
ve
r  
D
ia
be
te
s
A
cu
te
 a
pp
en
di
ci
tis
R
ig
ht
 T
O
A
TD
En
te
ro
co
cc
us
Pe
lv
ic
 a
de
no
-
A
bd
om
in
al
 d
is
te
nt
io
n
sp
ec
ie
s
ca
rc
in
om
a
4
67
Lo
w
er
 a
bd
om
in
al
 p
ai
n
D
ia
be
te
s
TO
A
 o
r a
dn
ex
al
R
up
tu
re
 o
f 
B
SO
E.
 co
li
N
on
e
m
al
ig
na
nc
y
rig
ht
 T
O
A
5
53
Lo
w
er
 a
bd
om
in
al
 p
ai
n
C
hr
on
ic
 h
ep
at
iti
s
Le
ft
 a
dn
ex
al
 tu
m
or
, 
Le
ft
 T
O
A
TA
H
,
N
ot
 c
ul
tu
re
d
N
on
e
su
sp
ic
io
us
 d
eg
en
-
B
SO
er
at
iv
e 
m
yo
m
a
6
68
Lo
w
er
 a
bd
om
in
al
 p
ai
n
—
Le
ft
 a
dn
ex
al
Le
ft
 T
O
A
TA
H
,
B
ac
te
ro
id
es
 fr
ag
ili
s
N
on
e
Va
gi
na
l d
is
ch
ar
ge
tu
m
or
, s
us
pi
ci
ou
s
B
SO
ov
ar
ia
n 
ca
nc
er
7
75
Lo
w
er
 a
bd
om
in
al
 p
ai
n
—
Pe
lv
ic
 tu
m
or
, s
us
pi
ci
ou
s 
R
ig
ht
 T
O
A
TA
H
,
Pr
ot
eu
s m
ira
bi
lis
,
R
ec
to
si
gm
oi
da
l
de
ge
ne
ra
tiv
e 
m
yo
m
a
B
SO
E.
 co
li
di
ve
rt
ic
ul
iti
s
or
 a
dn
ex
al
 m
al
ig
na
nc
y
8
57
Fe
ve
r 
D
ia
be
te
s
TO
A
R
ig
ht
 T
O
A
TD
E.
 co
li
SC
C
 o
r C
IN
 II
I
Lo
w
er
 a
bd
om
in
al
 p
ai
n
of
 c
er
vi
x 
9
55
Lo
w
er
 a
bd
om
in
al
 p
ai
n
—
A
dn
ex
al
 tu
m
or
, s
us
pi
ci
ou
s
Le
ft
 T
O
A
TA
H
, 
Pe
pt
os
tr
ep
to
co
cc
us
N
on
e
ad
ne
xa
l m
al
ig
na
nc
y
B
SO
sp
ec
ie
s
TO
A
=
tu
bo
ov
ar
ia
n 
ab
sc
es
s;
 R
SO
=
rig
ht
 s
al
pi
ng
o-
oo
ph
or
ec
to
m
y;
 T
A
H
=
to
ta
l a
bd
om
in
al
 h
ys
te
re
ct
om
y;
 L
SO
=
le
ft
 s
al
pi
ng
o-
oo
ph
or
ec
to
m
y;
 T
D
=
tr
an
sa
bd
om
in
al
 d
ra
in
ag
e;
 B
SO
=
bi
la
te
ra
l s
al
pi
ng
o-
oo
ph
or
ec
to
m
y;
 S
C
C
=
sq
ua
m
ou
s 
ce
ll
ca
rc
in
om
a;
 C
IN
 II
I=
ce
rv
ica
l i
nt
ra
ep
ith
el
ia
l n
eo
pl
as
m
 II
I.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3 237
Tuboovarian Abscesses in Postmenopausal Women
significant (Table 1). The rarity and muted presenta-
tion of TOAs in postmenopausal women may account
for the apparent difficulty in determining correct pre-
operative diagnosis, with malignancy-like adnexal/pelvic
tumor (n = 3) and acute appendicitis (n = 2) the most
prevalent of these misdiagnoses.
Several risk factors that predispose to TOA, such as
history of pelvic inflammatory disease and presence of
IUD, have been identified in reproductive women [8].
The frequency of IUD usage in our patients (27%) is
similar to analogous rates determined in other studies
(range, 20–54%) [7]. As might be expected, there was
a trend of a higher prevalence of IUD usage in our
premenopausal TOA patients (p = 0.10), with none of
the postmenopausal patients having the device. On
the other hand, contributing medical factors (e.g. dia-
betes) were more common in the latter group (p <
0.001). In contrast to the risk factors for pelvic inflam-
matory disease in women of childbearing age, medical
disorders resulting in impaired immune function play
an important role in the development of TOA in post-
menopausal women.
The predominant organisms isolated from TOA
aspirates were E. coli, B. fragilis, other Bacteroides species,
aerobic Streptococci, Peptococcus and Peptostreptococcus
[7]. The above microorganism spectrum is similar to
that of our premenopausal group. However, Proteus
species were another dominant organism in our post-
menopausal patients.
From a review of the English literature, we found that
25 of 68 reported postmenopausal TOA patients (37%)
had concomitant malignancies [1,2,4–6,9]. The pre-
dominant concomitant malignant tumors found in this
group were cervical cancer (n = 5), endometrial cancer
(n = 5), ovarian cancer (n = 4) and colon cancer (n = 4).
To our knowledge, there are only two studies comparing
the clinical characteristics of these two TOA groups
[1,2], with both demonstrating a significant association
between pelvic malignancy and postmenopausal TOA.
Coexisting pelvic malignancy was also more frequently
identified in our postmenopausal patients compared to
premenopausal patients (22% vs. 1.5%; p = 0.037).
Despite complete pre- and intraoperative investiga-
tions, however, concomitant pelvic malignancy may be
missed. Ben-Baruch et al found diagnostic delays rang-
ing from 2.5 to 13 months in all three postmenopausal
TOA patients with concomitant pelvic malignancy [4].
Heaton and Ledger also noted that one rectal carci-
noma was diagnosed several months after the initial
surgery for postmenopausal TOA [6]. Advanced pelvic
adenocarcinoma was identified in one of our patients
(case 3) 12 months postoperatively. Although pre- and
intraoperative examinations failed to reveal the lesion,
growth estimates suggest that it was probably present
at the time of surgery. Another subject (case 8) had
SCC or CIN III of the cervix on her Pap smear 9 months
after the initial surgical intervention. Although operative
interventions for TOA are usually urgent and preclude
detailed preoperative examination, thorough post-
operative investigations should be performed to exclude
concomitant malignancy in postmenopaual women
with TOA [1,2,4].
Gynecologic or enteric malignancy increases the risk
of TOA because of the following mechanisms. First, an
advanced cervical or endometrial cancer may impair the
endocervical barrier, rendering it more prone to infec-
tion or causing obstruction and subsequent entrap-
ment of blood and upper genital tract secretions,
which may serve as a culture medium and subsequently
lead to development of pyometra and/or TOA [2,5].
Second, local impairment of vascular supply and 
tissue necrosis by the malignancy also predispose to
infection [1,2,5]. Third, it seems reasonable to suggest
that direct seeding from an infected tumor or perfora-
tion of enteric tumors is a cause of abscess develop-
ment [4,6]. Finally, the malignancy may alter the host
in such a manner as to predispose to infection through
generalized immunosuppression [1].
Generally accepted indications for TOA surgery in
reproductive age women are signs of ruptured abscess,
failure to respond to medical therapy and question-
able diagnosis [1]. However, the presence of TOA has
been proposed as an additional indication for surgery
in postmenopausal women [1–3,6], based on the fact
that these patients are usually at higher risk of serious
consequences secondary to rupture with resultant sep-
ticemia. Further, conservative treatment may lead to
unnecessary delays in the diagnosis of occult cancer [2,7].
Conservative surgical procedures, in which the uterus
is left in place and any normal ovarian tissue is preserved,
may be an acceptable procedure in cases where preser-
vation of fertility and hormone function is desired [7].
Table 3. Associated surgical pathology stratified by menopausal status
Characteristic Premenopausal Postmenopausal p
Associated benign pathology 11 1 1.00
Associated malignant pathology 1 2 0.037
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Nonetheless, more radical surgery without preservation
of ovarian tissue may be a treatment strategy for post-
menopausal women to prevent abscess recurrence.
Both of our patients who underwent transabdominal
drainage as the initial surgical intervention (cases 3
and 8) experienced abscess recurrence and sepsis, with
one eventually dying from concomitant pelvic cancer
not found during initial abscess drainage. While conser-
vative surgical intervention (i.e. drainage of abscess or
unilateral adnexectomy) may be adopted by the gyne-
cologist as the preferred treatment strategy for TOA in
postmenopausal women, detailed preoperative and
even postoperative investigations for occult gyneco-
logic and enteric cancer should be performed to
ensure the long-term efficacy of treatment.
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